Medicine
Methylphenidate 36 mg extended-release tablet
Methylphenidate 36 mg extended-release tablet is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Protect from humidity.
Key facts
- Active ingredient (INN)
- Methylphenidate
- Brand
- Sold under the generic name
- Strength
- 36 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets, 30 blister pack and 7 more
- Manufacturers
- Camber PharmaceuticalsIndiaLannettActavis PharmaAmerican Health PackagingBryant Ranch PrepackGolden State Medical SupplySpecGxTrigen LaboratoriesXLCare Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Protect from humidity.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CII
- ATC code
- N06BA04 Methylphenidate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 December 2012
- Identifiers
- RxCUI 1091155, 1091170, 1091185 +6DailyMed set ID b9af3104-172d-4975-9301-b9fe7db9ef12, f6581305-cd1e-4171-8c1b-e184c7bde033, c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f +7NDC 31722-954, 60687-554, 13811-708 +7Application ANDA211009, ANDA205327, ANDA202608 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, extended release in 1 bottle | 31722-954-01 | Camber PharmaceuticalsIndia | 3 September 2019 |
| 100 tablet, extended release in 1 bottle | 0527-3312-37 | Lannett | 24 April 2019 |
| 100 tablet, extended release in 1 bottle | 62175-312-37 | Lannett | 23 September 2013 |
| 100 tablet, film coated, extended release in 1 bottle | 62037-726-01 | Actavis Pharma | 4 March 2019 |
| 100 tablet, extended release in 1 bottle | 0406-0136-01 | SpecGx | 28 December 2012 |
| 100 tablet, extended release in 1 bottle | 13811-708-10 | Trigen Laboratories | 14 August 2017 |
| 100 tablet, extended release in 1 bottle | 72865-135-01 | XLCare Pharmaceuticals | 24 February 2020 |
| 30 blister pack in 1 box, unit-dose / 1 tablet, extended release in 1 blister pack | 60687-554-21 | American Health Packaging | 25 June 2020 |
| 100 tablet, extended release in 1 bottle | 72162-2394-1 | Bryant Ranch Prepack | 17 March 2026 |
| 100 tablet, extended release in 1 bottle | 51407-926-01 | Golden State Medical Supply | 21 June 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Methylphenidate 36 mg extended-release tablet.
Other strengths and forms of Methylphenidate
Clinical summary
Methylphenidate is a central nervous system stimulant indicated for the treatment of attention Deficit Hyperactivity Disorders (ADHD) in pediatric patients 6 years and older and adults, among other approved uses. MedsAcross supplies Methylphenidate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MethylphenidateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ritalin prescribing information (Sandoz) · U.S. National Library of Medicine, DailyMed
- Tuzulby: European public assessment report (EPAR) · European Medicines Agency
Need Methylphenidate 36 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.